Thermo Fisher Scientific announced the global launch of the Gibco CTS Compleo Fill and Finish System, an automated, functionally closed solution designed to streamline formulation and filling in cell therapy manufacturing.
Because cell therapies often begin with patient-derived cells, manufacturing workflows must accommodate variability in cell count, concentration and viability. As more therapies move toward commercialization, manufacturers are seeking to reduce manual intervention and improve operational efficiency while maintaining strict requirements for sterility, dose accuracy and product consistency.
Formulation and filling have been traditionally performed using manual methods that require careful handling of fragile cells in small volumes, introducing variability and risk of contamination. The CTS Compleo system offers a compact, automated, functionally closed solution for formulation and filling, helping reduce manual intervention and supporting consistent batch-to-batch performance.
Furthermore, Thermo Fisher provides comprehensive services to support implementation of the CTS Compleo system, including installation, application and process development support, and global service coverage.
